1-877-804-4900

2017 myMatrixx Leadership Development Program

Tampa, FL, January 19, 2017 — The second Leadership Development Program (LDP) was launched last week. Robin Kraemer, SVP of Human Resources and program administrator, is excited about this high potential class. The program, she says, is designed to accelerate the learning and exposure for future leaders at myMatrixx. The program is a six-month commitment […]

READ MORE

Tina Dumar Named as a Finalist for CFO of the Year

Tampa, FL, January 17, 2017 – Congratulations to Tina Dumar, our Chief Financial Officer (CFO) and Treasurer, for being named by the Tampa Bay Business Journal as a finalist for 2017 CFO of the Year. Tina was selected over dozens of applicants based on her leadership role within the organization, contributions to community initiatives, impact […]

READ MORE

Tampa Office Teams Up with the Boys & Girls Club for a Holiday Gift Tree

Tampa, FL, December 21, 2016 – myMatrixx employees truly felt the holiday spirit and the season of giving when they donated gifts to the Belmont Heights chapter of the Boys & Girls Club. This year kicked off the start of a new tradition when myMatrixx teamed with Boys & Girls Club of Tampa Bay Director, […]

READ MORE

myMatrixx Sponsors Wreaths Across America

Tampa, FL, December 17, 2016 – myMatrixx is proud to sponsor Wreaths Across America. Every December, Wreaths Across America coordinates wreath-laying ceremonies all across the country on the graves of fallen soldiers. National Wreaths Across America Day was held on December 17 and myMatrixx participated, donating 15 wreaths that were distributed at the American Legion […]

READ MORE

Artemis Emslie Speaks at University of Tampa’s Business Network Symposium

Tampa, FL, October 31, 2016 — myMatrixx CEO, Artemis Emslie, in a joint effort with the CEOs of Odyssey Marine Exploration and SynDaver Labs, helped kick off The University of Tampa Board of Fellows’ Business Network Symposium on October 25. The symposium is a complimentary information session for the Bay area business community and the […]

READ MORE

New York Workers’ Compensation Board Has Published a New Pharmacy Benefit Plan

October 7, 2016 – The New York Workers’ Compensation Board has released a bulletin pertaining to their research into a formulary, requirements for pre-approval/prior authorization, and for utilization review. The new Pharmacy Benefit Plan proposed requires insurers provide pharmacy benefits management services, introduces a prescription drug formulary, imposes limitations on the prescribing of compounded medications, […]

READ MORE

Tina Dumar Recognized as a Finalist for Business Woman of the Year

Tampa, FL, September 23, 2016 –– Congratulations to our Chief Financial Officer, Tina Dumar, on being recognized as a finalist in the Health & Wellness category for Business Woman of the Year by the Tampa Bay Business Journal. She was selected as a finalist over hundreds of applicants. Tina is an accomplished accounting and finance […]

READ MORE

Mike Geis Wins CIO of the Year

Tampa, FL, August 25, 2016 – Mike Geis, Chief Information Officer for myMatrixx, has been recognized as the Tampa Bay Business Journal’s CIO of the Year in the private, medium-size business category. Mike was selected over hundreds of applicants based on his outstanding accomplishments, exceptional leadership skills and strong commitment to the community. We are […]

READ MORE

myMatrixx is Listed on Inc. 5000

Tampa, FL, August 22, 2016 – myMatrixx made the prestigious Inc. 5000 list, ranking #4103. This is the eighth year the company has earned a spot on the nationally recognized list.  myMatrixx is only one of three Tampa-based companies to make the list for several consecutive years.

READ MORE

myMatrixx Donates Hundreds of School Supplies to Ferrell Girls Preparatory Academy

Tampa, FL, August 11, 2016 – myMatrixx employees were delighted to host an annual back to school drive for Ferrell Girls Preparatory Academy in Tampa, Florida for the second year in a row. Ferrell’s mission is to empower girls to excel in rigorous academics and character education while fostering them to be positive forces in […]

READ MORE

myMatrixx was named a Fast 50 company by the Tampa Bay Business Journal

Tampa, FL, July 21, 2016 – In 2016, myMatrixx was named a Fast 50 company by the Tampa Bay Business Journal. Fast 50 is a list of the fastest growing privately held companies in the Tampa Bay region.  myMatrixx has been earned a spot on the Fast 50 list every year since 2006.

READ MORE

myMatrixx Welcomes Viviana Brantley as General Manager of Pharmacy

TAMPA, April 25, 2016 – myMatrixx, a Tampa-based pharmacy and ancillary medical benefit management company, announced that Viviana Brantley has joined the company’s executive team as General Manager of Pharmacy.  In this role, Brantley is responsible for oversight of all aspects of the pharmacy operations and clinical teams. Brantley has more than 25 years of management […]

READ MORE

Artemis Emslie Promoted to CEO

April 1, 2016 – Artemis Emslie has been promoted to Chief Executive Officer of myMatrixx. Artemis joined the myMatrixx team in 2012 as President. Under her leadership, myMatrixx has experienced significant revenue growth, increased profitability, and an expanded corporate footprint. During her tenure at myMatrixx, Artemis also co-founded the Alliance of Women in Workers’ Compensation, […]

READ MORE

Tina Dumar Promoted to CFO

Tampa, FL, March 2016 – Tina Dumar has been promoted to Chief Financial Officer and Treasurer of myMatrixx. After first serving as a financial consultant, Tina joined myMatrixx as VP of Finance in 2008. Through her leadership, myMatrixx has successfully implemented an improved financial forecasting system that enables the management team to have full visibility […]

READ MORE

Coolest Office Space TBBJ

Tampa, FL, February 2016 – myMatrixx’s corporate headquarters in Tampa, Florida was ranked #3 on the Tampa Bay Business Journal’s list of Coolest Office Spaces.

READ MORE

myMatrixx Chief Clinical Officer Phil Walls Honored as CompPharma’s 2015 Person of the Year

TAMPA, FL, December 18, 2015 – Phil Walls, Chief Clinical Officer for myMatrixx, has been recognized as CompPharma’s Person of the Year for 2015. CompPharma is a consortium of workers’ compensation pharmacy benefit management (PBM) companies that provides a platform for developing cost-effective tools and services that benefit its PBM members.  myMatrixx, a Tampa-based pharmacy […]

READ MORE

myMatrixx Celebrates New Corporate Office to Accommodate Growth

TAMPA, December 11, 2015 – myMatrixx, a Tampa-based pharmacy and ancillary medical benefit management company, hosted an open house for local dignitaries, myMatrixx clients and vendors to celebrate the company’s new corporate headquarters located at 3111 W. Martin Luther King Blvd. in the Tampa Bay Park office complex. More than 100 guests, including the City […]

READ MORE

myMatrixx President Artemis Emslie Named to 2015 “Women to Watch” List

One of 25 Women Honored as Leaders in the Insurance Industry TAMPA, December 8, 2015 – myMatrixx, a Tampa-based pharmacy and ancillary medical benefit management company, announced that Artemis Emslie, President of myMatrixx, has been recognized by Business Insurance magazine as an honoree on their 2015 “Women to Watch” list. The annual list spotlights 25 […]

READ MORE

myMatrixx Recognized with “Fast 50” Award

myMatrixx Recognized with “Fast 50” Award Tampa, FL, July 28, 2015 – myMatrixx, a pharmacy and ancillary medical benefit manager for workers’ compensation, announced today that the Tampa Bay Business Journal has named myMatrixx to their annual “Fast 50” list of the fastest growing privately-held companies in the Tampa Bay area. The company’s impressive $37 million growth (50.77%) over […]

READ MORE

myMatrixx is pleased to announce a new benefit for our clients: “FaceTime with Phil.”

Phil Walls, our Chief Clinical Officer, is a clinical pharmacist with over 25 years of experience. He is a nationally recognized speaker, author, and a forward-thinking leader who has implemented groundbreaking clinical programs currently in use by the largest workers’ compensation carriers in the nation. We would like to offer the opportunity for your team […]

READ MORE

myMatrixx Relocation Announcement

Tampa, Florida, May 18, 2015 – myMatrixx®, a pharmacy and ancillary benefit management company, is very excited to announce its relocation to the following address: 3111 W. Martin Luther King Boulevard Suite 800 Tampa, FL 33607 myMatrixx has grown from 120 employees in January 2012 to 220 employees presently. Employees at the older facility were […]

READ MORE

Dyloject™ Approved by the U.S. Food and Drug Administration (FDA)

The U.S Food and Drug Administration (FDA) has approved Dyloject™ (diclofenac sodium) injection by Hospira, Inc. Dyloject™ is a new formulation of diclofenac sodium, which is a proprietary non-steroidal anti-inflammatory drug (NSAID) indicated in adults for the management of mild to moderate pain and management of moderate to severe pain alone or in combination with […]

READ MORE

Kansas 2015 Fee Schedule Controls Pharmacy Spend

The Kansas Department of Labor, Division of Workers’ Compensation 2015 Schedule of Medical Fees includes two important revisions related to pharmacy spend. For dates of service effective January 1, 2015, physicians must obtain prior approval for compounds and physician dispensed drugs. If the payer approves compound and/or physician dispensed medications, the reimbursement will be the […]

READ MORE

myMatrixx Compliance and Government Affairs Director Jaelene Fayhee receives CompPharma Person of the Year Award

TAMPA, December 4, 2014 – myMatrixx, a Tampa-based pharmacy and ancillary medical benefit management company, announced that Jaelene Fayhee, Compliance and Government Affairs Director for myMatrixx, has been recognized as the recipient of CompPharma’s Person of the Year award for 2014. Helen Knight, CompPharma Vice President stated, “I can’t say enough wonderful things about Jaelene […]

READ MORE

FDA approves Hysingla ER (hydrocodone Bitartrate) an extended release opioid analgesic

On November 20 the FDA announced that they have approved Hysingla ER. Hysingla ER is the second approved hydrocodone extended release opioid analgesic. The first, Zohydro ER, was approved earlier in the year but does not have the abuse-deterrent formulation. The FDA appears to be following up on its desire to make available opioid analgesics […]

READ MORE

Physician Dispensing Reform Adopted in Pennsylvania

Pennsylvania Governor Tom Corbett signed legislation yesterday reforming physician dispensing practices. HB 1846 addresses both reimbursement and timeframes for dispensing repackaged drugs. Supporters expect the new law to save Pennsylvania employers approximately $13 million annually in workers’ compensation costs. The law will take effect on December 26, 2014, and includes the following provisions: Physician dispensing […]

READ MORE

Hydrocodone Reclassification Initiative Update

The Drug Enforcement Agency’s initiative to reschedule hydrocodone-containing products (Lortab®, Vicodin®, Norco®, et al.) from Schedule III to Schedule II went into effect on October 6, 2014. To summarize the important considerations, these medications can now only be filled with a hard copy prescription (no phoned in or faxed in prescriptions allowed), and refills are […]

READ MORE

myMatrixx SVP Lindsay Rios Named to 2014 “Women to Watch” List

TAMPA, October 10, 2014 – myMatrixx, a Tampa-based pharmacy and ancillary medical benefit management company, announced that Lindsay Rios, Senior Vice President of myMatrixx Operations, has been recognized by Business Insurance magazine as an honoree on their 2014 “Women to Watch” list. The annual list spotlights 25 women who are doing outstanding work in commercial […]

READ MORE

FDA Approves Movantik (naloxegol) for Opioid-induced Constipation

On September 16, the FDA announced that they have approved Movantik (naloxegol).  Movantik is the first approved once daily, peripherally-acting mu-opioid receptor antagonist for opioid-induced constipation in adults with chronic non-cancer pain. Movantik should be taken once a day on an empty stomach at least 30 minutes before the first meal or two hours after […]

READ MORE

myMatrixx Honored with “Best Places to Work in Insurance” Award

Tampa, FL, September 17, 2014 – myMatrixx, a pharmacy and ancillary medical benefit manager for workers’ compensation, announced today that Business Insurance magazine has awarded myMatrixx with a “Best Places to Work in Insurance” distinction for the third year in a row. Best Places to Work is a joint effort of Business Insurance and the Best Companies Group.  The competition, […]

READ MORE

myMatrixx Announces Expanded Role for Medical Director Steven P. Stanos, Jr., DO

Tampa, FL, September 10, 2014 — myMatrixx has extended its contract with its Medical Director, Dr. Steven Stanos with an expanded role that includes direct involvement in the myMatrixx clinical pharmacy program. Dr. Stanos, a nationally recognized physiatrist and pain management specialist, published author, and frequent speaker on topics related to rehabilitation and workers’ compensation, is […]

READ MORE

myMatrixx Ranks on the Inc. 5000 for the Sixth Consecutive Year

myMatrixx No. 4057 on Annual List of America’s Fastest-Growing Private Companies by Inc. Magazine Inc. magazine today ranked myMatrixx NO. 4057 on its 33rd annual Inc. 500|5000, an exclusive ranking of the nation’s fastest-growing private companies. The list represents the most comprehensive look at the most important segment of the economy—America’s independent entrepreneurs. Companies such as […]

READ MORE

FDA Approves New Type of Sleep Drug, Belsomra

This week The U.S. Food and Drug Administration approved Belsomra (suvorexant) tablets for use as needed to treat difficulty in falling and staying asleep (insomnia). Belsomra should be taken no more than once per night, within 30 minutes of going to bed, with at least seven hours remaining before the planned time of waking. The […]

READ MORE

Regulatory Recap – August

This month’s recap covers the latest legislative activity and news impacting workers’ compensation including: • Physician Dispensing • Fee Schedules • Medical Fee Guidelines • Treatment Guidelines • And much more. Read the issue here for the latest news.

READ MORE

FDA Approves New Extended-Release Opioid

The FDA has approved Targiniq® ER, an extended-release/long-acting (ER/LA) opioid analgesic with FDA-approved labeling describing the product’s properties that are expected to reduce, but not totally prevent, abuse by snorting or injecting. Description(1) Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended-release tablets) is a combination product containing an opioid agonist, oxycodone, and an opioid antagonist, […]

READ MORE

Texas SORM Selects myMatrixx as PBM

myMatrixx has been selected by the Texas State Office of Risk Management (SORM) to be the pharmacy benefit manager for the Government Employees Workers’ Compensation program. myMatrixx is excited to partner with SORM on their program. For more information visit the SORM website here.

READ MORE

Regulatory Recap: July 2014

In this month’s Regulatory Recap we cover the most recent legislative news impacting workers’ compensation in the following areas: > Physician Dispensing > Prescription Authority > Compounds > Fee Schedules > And more Read the issue here for the latest news.

READ MORE

Recall: Coumadin for Injection

Coumadin (warfarin sodium) for Injection by Bristol-Myers Squibb: Recall – Particulate Matter AUDIENCE: Cardiology, Health Professionals ISSUE: Bristol-Myers Squibb Company issued a voluntary recall of six lots of Coumadin for Injection, 5 mg single-use vials in the U.S. Visible particulate matter was found in a small number of Coumadin for Injection unreleased samples. Injected particulate […]

READ MORE

Prescription drugs overtake cannabis in fatal crashes

From the University of Nebraska Medical Center   Since 1993, the profile of a drugged driver has changed substantially. A study released today in Public Health Reports shows that more drivers are now testing positive for prescription drugs, cannabis, and multiple drugs, and they are more likely to be older than 50. “While we’ve seen […]

READ MORE

Regulatory Recap June 2014

In this month’s Regulatory Recap we cover the most recent legislative news impacting workers’ compensation in the following areas: – Prescription Drug Monitoring Programs – Treatment Guidelines – Compensability and much more Read the issue here for the latest news.

READ MORE

New Issue of Monitor Newsletter

Today myMatrixx released a new issue of the Monitor, our quarterly newsletter covering workers’ compensation news and topics. In this issue, myMatrixx reviews another new extended release opioid approved by the FDA – Xartemis, you’ll learn how to effectively manage medical supply costs, and read how prescription drug monitoring programs are becoming an effective tool […]

READ MORE

This Thursday – Understanding Compounds in Comp

myMatrixx’s Phil Walls will be a panelist on the IAIABC Webinar – Understanding Compounds in Comp this Thursday, May 29th at 12:00 PM, EST Register now to reserve your spot! Click here. The use of compound drugs in workers’ compensation has grown significantly in the past five years. The authors of a new report, Compounding is […]

READ MORE

Maryland Passes Bill 1099, Presumption of Compensability

Workers’ Compensation – Occupational Disease Presumptions – Paid Rescue Squad Members and Paid Advanced Life Support Unit Members Jurisdiction: Maryland Bill #: SB 1099 Effective Date: 10/01/2014 Bill Summary: Extends the presumption of compatibility under the Workers’ Compensation Law to include paid rescue squad members and paid advanced life support unit members who suffer from […]

READ MORE

Watch Out Missouri – Part 2

From WorkCompWire, Leaders Speak Article, Phil Walls, RPh, Chief Clinical and Compliance Officer, myMatrixx   As stated last week, as the only state that does not have a prescription drug monitoring program (PDMP) in place, Missouri runs the risk of becoming the nation’s next pill mill. Although PDMPs are the best tool currently available to combat fraud, […]

READ MORE

Watch Out Missouri – WorkCompWire Leaders Speak

From WorkcompWire by Phil Walls, RPh, Chief Clinical and Compliance Officer, myMatrixx   Prescription Drug Monitoring Programs Aim to Stop Fraud and Abuse of Controlled Substances. A prescription drug monitoring program (PDMP) is a statewide electronic database of certain controlled substance prescriptions that have been dispensed in that state or into that state by an out-of-state mail […]

READ MORE

Drug Information Update: Epidural Corticosteroid Injections

FDA requires label changes to warn of rare but serious neurologic problems after epidural corticosteroid injections for pain. The U.S. Food and Drug Administration (FDA) is warning that injection of corticosteroids into the epidural space of the spine may result in rare but serious adverse events, including loss of vision, stroke, paralysis, and death. The […]

READ MORE

Specialty Drugs Exploding on the Marketplace

From Risk & Insurance  Last year, costs for specialty drugs were all but nonexistent for workers’ comp payers. Now, they comprise about 2 percent of the drug spend for clients of myMatrixx with no signs of slowing down. The pharmacy benefit management and ancillary services company is putting workers’ comp practitioners on notice to watch […]

READ MORE

Judge blocks Massachusetts ban on Zohydro

From ABC News  –  U.S. District Court Judge Rya Zobel on Tuesday issued a preliminary injunction after the maker of the drug, Zogenix, argued in a lawsuit that the ban ordered by Gov. Deval Patrick last month is unconstitutional. Zobel said in issuing the injunction that Massachusetts appears to have overstepped its authority in banning […]

READ MORE

FDA approves new hand-held auto-injector to reverse opioid overdose

First naloxone treatment specifically designed to be given by family members or caregivers. FDA News Release: The U.S. Food and Drug Administration today approved a prescription treatment that can be used by family members or caregivers to treat a person known or suspected to have had an opioid overdose. Evzio (naloxone hydrochloride injection) rapidly delivers […]

READ MORE

Massachusetts Bans Zohydro and Declares Public Health Emergency

Governor Deval Patrick today declared a public health emergency in Massachusetts in response to the growing opioid addiction epidemic. The Governor directed the Department of Public Health (DPH) to take several action steps that will combat overdoses, stop the epidemic from getting worse, help those already addicted to recover and map a long-term solution to […]

READ MORE

myMatrixx Contributes to CompPharma White Paper

Today CompPharma released the white paper Compounding is Confounding Workers’ Compensation, on the use of compounds in injured workers. myMatrixx’s Phil Walls, RPh, Chief Clinical and Compliance Officer as well as Michael Nguyen, PharmD are contributing authors. The use of compounded drugs has increased five-fold in the last five years, raising questions about their use […]

READ MORE

Indiana’s Governor Signs Physician Dispensing Reform Law

myMatrixx President Artemis Emslie applauds Governor Mike Pence (R-IN) for recently signing SB 294 into law. “SB 294 includes a very important reform provision for patient safety and for controlling the high costs associated with physician dispensing of medication under Indiana’s Workers’ Compensation Act”. SB 294 includes a reform provision enhancing the state law that […]

READ MORE

FDA Medwatch: Effexor XR and Venlafaxine HCl Recall

Effexor XR 150 Mg Extended-Release Capsules (Pfizer) and Venlafaxine HCl 150 Mg Extended-Release Capsules (Greenstone): Recall – Possible Presence of Tikosyn Capsules Read the MedWatch safety alert here. ISSUE: Pfizer Inc. issued a voluntary recall of one lot of 30-count Effexor XR (venlafaxine HCl) 150 mg extended-release capsules, one lot of 90-count Effexor XR (venlafaxine HCl) […]

READ MORE

New Issue of myMatrixx Newsletter Released

myMatrixx has released Issue 1, 2014 of the Monitor. In this issue our team reviews the pros and cons of the new Hepatitis C Drug Sovaldi, we take a look back at events in 2013 and how they will impact workers’ comp this year, you’ll gain some helpful tips to successfully manage your next orthotics order, […]

READ MORE

FDA Drug Information Update: Acetaminophen

Clinical News – January 15, 2014 In January 2011 the U.S. Food and Drug Administration (FDA) asked manufacturers to limit the amount of acetaminophen in each dose (tablet or capsule) to no more than 325mg by January 14, 2014 for all prescription products. The FDA is now requesting that health care professionals discontinue prescribing and […]

READ MORE

myMatrixx Promotes Michael Geis to Chief Information Officer

Tampa, Florida, January 10, 2014 – myMatrixx®, a pharmacy and ancillary benefit management company for workers’ compensation programs, announced today that Michael Geis has been promoted to Chief Information Officer. He joined the company in 2011 as the Vice President of Information Services responsible for the organization’s IT infrastructure, security and compliance. During his tenure, Mike […]

READ MORE

Texas, Oklahoma & Alabama Regulatory Updates

Treatment Guidelines •   The Oklahoma Workers’ Compensation Commission (OWCC) has proposed emergency rules to implement the Administrative Workers’ Compensation Act, including rules which would establish a closed formulary and a transition period for legacy claims. The closed formulary definition is similar to the definition adopted in Texas with one important difference.  Drugs that are not […]

READ MORE

Workers compensation industry braces for impact of medical marijuana

Employers urged to set policies on marijuana The legalization of medical marijuana in nearly two dozen states has the workers compensation industry on guard for a potential surge of claims seeking payment for the drug. The National Council on Compensation Insurance Inc. highlighted medical marijuana as one of the top emerging workers comp issues to […]

READ MORE

2013 Regulatory Update

Prescription Drug Abuse Legislation for Workers’ Compensation During the 2013 legislative session, many states considered and adopted legislation to address prescription drug abuse.  Some state legislatures also appointed special committees to study this national epidemic. myMatrixx has posted a report listing enacting legislation related to prescription drug monitoring programs,  workers’ compensation pharmacy benefits  and medical […]

READ MORE

FDA Drug Update on Acetaminophen

The U.S. Food and Drug Administration (FDA) issued a Drug Information Update about acetaminophen containing products.  As cold and flu season hits this year it is important for everyone to remember that acetaminophen or “Tylenol” is found in more than 600 over-the-counter (OTC) and prescription medications.  Acetaminophen is used as a fever reducer and pain […]

READ MORE

myMatrixx Named a Best Places to Work in Insurance By Business Insurance

Tampa, Florida, September 6, 2013 – myMatrixx, a pharmacy benefit manager and ancillary services  company for workers’ compensation, announced today that the organization has been named by Business Insurance a Best Places to Work in Insurance for the second year in a row. Best Places to Work is a joint effort of Business Insurance and the Best […]

READ MORE

Rudy Flores Joins myMatrixx as Director of Sales in West Region

Tampa, Florida, August 9, 2013 – myMatrixx, a pharmacy and ancillary medical benefits management company for workers’ compensation, announced today that Rudy Flores has joined the organization as Director of Sales for the West Region. In this role, Rudy will be responsible for new business development for the organization’s pharmacy benefit management and ancillary services. […]

READ MORE

myMatrixx Launches Mobile Tool to Manage Workers’ Compensation Claims

Tampa, Florida, April 2, 2013 – myMatrixx®, a pharmacy and ancillary benefit management company, today released the patent pending myMatrixx Mobile℠, the first tool designed for both claims professionals and injured workers to manage workers’ compensation claims. Developed for myMatrixx’s clients and their patients, they will have the ability to login to the mobile site […]

READ MORE

myMatrixx Dramatically Reduces Opioid Spend for Catastrophic Claim

Tampa, Florida, February 4, 2013 – myMatrixx, a pharmacy benefit management and ancillary medical services company serving workers’ compensation announced today the release of a new case study resulting in savings of over $250,000 per year for one claimant. The study titled “Unmanageable or Simply Unmanaged? A Look Inside An Opioid Drug Treatment Case” reviews […]

READ MORE

myMatrixx Names Ann Pointer General Counsel

myMatrixx, a pharmacy and ancillary medical benefits management company focused on the workers’ compensation market, announced today that Ann Pointer has joined the organization as General Counsel. In this role she will be responsible for managing the legal, risk management, compliance and privacy aspects of myMatrixx operations.  Ann will be instrumental in the continued success […]

READ MORE

myMatrixx Receives URAC Accreditation

Tampa, Florida, December 11, 2012 – myMatrixx, a pharmacy benefit management and ancillary medical services company, announced today that it has been awarded accreditation for Workers’ Compensation and Property and Casualty Pharmacy Benefit Management from URAC, a Washington, DC-based health care accrediting organization that establishes quality standards for the health care industry. “We are honored […]

READ MORE

myMatrixx on Business Insurance 2012 Best Places to Work in Insurance

by

Tampa, Florida, September 5, 2012 – myMatrixx, a pharmacy and ancillary medical benefits management company focused on the workers’ compensation market, announced today the company has been named a Business Insurance Best Places to Work in Insurance. The national program is designed to identify and recognize high-quality workplaces with at least 25 employees in the […]

READ MORE

myMatrixx Ranks No. 2245 on the 2012 Inc. 500|5000

TAMPA, August 23, 2012 — Inc. magazine has ranked myMatrixx No. 2245 on its sixth annual Inc. 500|5000, an exclusive ranking of the nation’s fastest-growing private companies. This is the fourth year myMatrixx has made the list. The company also ranks 29th of the top companies from the Tampa Bay area and No. 182 of […]

READ MORE

myMatrixx Chief Clinical and Compliance Officer Phil Walls to Speak at PRIMA’s Annual Conference

Tampa, Florida, June 1, 2012 – Phil Walls, R.Ph., the Chief Clinical and Compliance Officer for myMatrixx, a full-service pharmacy benefit management and ancillary medical services company, will speak at the Public Risk Management Association’s (PRIMA’s) 2012 Annual Conference.  Along with the City of Tampa’s Risk Manager Michael Laperche, MBA, CSP, RMPE, Walls will examine […]

READ MORE

myMatrixx President Artemis Emslie to Address the 2012 Annual Meeting of the National Council of Self-Insurers

Tampa, Florida, May 31, 2012 – Artemis Emslie, the president of myMatrixx, a full-service pharmacy and ancillary medical benefits management company, will speak at the 2012 Annual Meeting of the National Council of Self-Insurers. An industry veteran with more than 20 years experience in workers’ compensation and pharmacy benefit management (PBM), Emslie will discuss how […]

READ MORE

myMatrixx Names Craig Rollins, Vice President of Ancillary and Business Development

Tampa, Florida, May 14, 2012 – myMatrixx®, a full-service pharmacy benefit management and ancillary medical benefits company for workers’ compensation, announced today that Craig Rollins has joined the organization as Vice President of Ancillary and Business Development. In this role he will be responsible for the strategic growth of myMatrixx’s Ancillary Division which includes the […]

READ MORE

myMatrixx Names Artemis Emslie to President Position

Tampa, Florida, January 17, 2012 – myMatrixx®, a full-service pharmacy and ancillary medical benefits management company announced today that Artemis Emslie has been named to the new position of President. With rapid expansion year over year, the new position was created to continue myMatrixx’s focus on growth and exceptional customer service. In the position, Ms. […]

READ MORE

Contact us

1-877-804-4900

Subscribe

Search

Connect